The Shivom Public Sale has ended successfully. We are pleased to announce that we have achieved our hardcap of $35 million in less than 15 seconds owing to spectacular response from all our supporters.

Current genomic databases despite being extremely valuable for research, often lack a diverse representation of ethnic groups from around the globe and this limits their ability to benefit from advances

Project Shivom features as the top ICO in Coinspeaker's Weekly Report and ranks amongst the top three most successful ICO's in Drugs and Healthcare category to date. Check out this amazing analysis by